Patents by Inventor Stéphane Bejanin

Stéphane Bejanin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gssp4 polynucleotides and polypeptides and uses thereof
    Publication number: 20050075285
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GSSP4 polypeptides have been identified that are believed to be beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing cholesterol levels, body mass, body fat, and for treating metabolic-related diseases and disorders. The metabolic-related diseases or disorders envisioned to be treated by the methods of the invention include, but are not limited to: obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, diabetes, glucose intolerance, insulin resistance and hypertension.
    Type: Application
    Filed: February 7, 2002
    Publication date: April 7, 2005
    Inventors: Barbara Bour, John Chicca, Blake Denison, Frances Yen-Potin, Bernard Bihain, Stephane Bejanin, Hiroaki Tanaka, Severin Jobert, Jean-Yves Giordano, Jean-Baptiste Dumas Milne Edwards
  • Human CDNAS and proteins and uses thereof
    Publication number: 20050026182
    Abstract: The invention provides polynucleotides and polypeptides encoding an isolated amyloid inhibitor protein (APIP) and compositions thereof. The polypeptides of the subject invention can be used to inhibit the catabolism or sequential cleavage of amyloid beta precursor protein (APP) by Sequential cleavage of APP by beta secretase and gamma secretase.
    Type: Application
    Filed: May 3, 2004
    Publication date: February 3, 2005
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Isolated amyloid inhibitor protein (APIP) and compositions thereof
    Patent number: 6794363
    Abstract: The invention provides polynucleotides and polypeptides encoding an isolated amyloid inhibitor protein (APIP) and compositions thereof. The polypeptides of the subject invention can be used to inhibit the catabolism or sequential cleavage of arnyloid beta precursor protein (APP) by Sequential cleavage of APP by beta secretase and gamma secretase.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: September 21, 2004
    Assignee: Genset S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Publication number: 20030198954
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: November 14, 2001
    Publication date: October 23, 2003
    Applicant: GENSET, S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Publication number: 20030170628
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: November 14, 2001
    Publication date: September 11, 2003
    Applicant: GENSET, S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Publication number: 20030162186
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: May 22, 2002
    Publication date: August 28, 2003
    Applicant: GENSET, S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Publication number: 20030157485
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: November 13, 2001
    Publication date: August 21, 2003
    Applicant: GENSET, S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Publication number: 20030118997
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: October 15, 2001
    Publication date: June 26, 2003
    Applicant: GENSET, S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Publication number: 20030096247
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: November 14, 2001
    Publication date: May 22, 2003
    Applicant: GENSET, S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Publication number: 20030092011
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: November 14, 2001
    Publication date: May 15, 2003
    Applicant: GENSET, S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Publication number: 20030027248
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: August 6, 2001
    Publication date: February 6, 2003
    Applicant: GENSET, S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Human cDNAs and proteins and uses thereof
    Publication number: 20030027161
    Abstract: The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.
    Type: Application
    Filed: November 13, 2001
    Publication date: February 6, 2003
    Applicant: GENSET, S.A.
    Inventors: Stephane Bejanin, Hiroaki Tanaka
  • Recombinant expression of the rat vesicular acetylcholine transporter
    Patent number: 6235497
    Abstract: A nucleic sequence coding for a protein involved in the vesicular transport of acetylcholine, the corresponding protein and the promoter sequences implicated in expressing said protein are disclosed. The invention also discloses expression vectors containing said sequence and the therapeutic use of said sequence or said vectors.
    Type: Grant
    Filed: April 21, 1997
    Date of Patent: May 22, 2001
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Stéphane Bejanin, Sylvie Berrard, Riccardo Cervini, Jacques Mallet